VAGISAN MYKO KOMBI

This brand name is authorized in Croatia, Germany.

Active ingredients

The drug VAGISAN MYKO KOMBI contains one active pharmaceutical ingredient (API):

1	Clotrimazole UNII G07GZ97H65 - CLOTRIMAZOLE
	Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc.
	Read more about Clotrimazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G01AF02	Clotrimazole	G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AF Imidazole derivatives
Discover more medicines within G01AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	09235710, 15373698
HR	Agencija za lijekove i medicinske proizvode	HR-H-343372982